October 15-17, 2012

Chicago520-722-2000www.sourceg.net

AS SEEN IN:

next IND is an integrated network of drug developmentexperts; combining the convenience of full-service CROswith the unique advantages and expertise of niche CROs.The next IND network consists of six companies; all best-in-class, covering all aspects of nonclinical (in vitro andin vivo), chemistry manufacturing and controls (drug sub-stance and drug product) and clinical services. Their innovative network provides astreamlined approach to drug development designed to reduce cost and time-to-marketwhile maintaining an exceptional level of quality, communication and trust.

Visit Booth #1441 and find out how next IND can revolutionize your drug develop-ment process!

next IND partners include:XenoTech provides an integrated suite of drug development solutions including

drug discovery, nonclinical safety assessment and preclinical development. XenoTechdevelops and deploys customized and flexible drug development plans. As a partnerin “next IND”, XenoTech facilitates the understanding of in vitro ADME toward ob-taining a better understanding of the mechanistic implications for uptake, metabolismand clearance of active moieties.

Xenometrics is a GLP compliant, USDA registered, AAALAC accredited contractresearch organization, providing preclinical study services to the pharmaceutical andbiotech industry. Xenometrics’ services include: DMPK, General Toxicology, SafetyPharmacology and Development & Reproductive Toxicology Studies. As a partner in“next IND,” Xenometrics assists clients with their research and development needs; fromearly stage research, to IND enabling studies, and further preclinical safety studies to sup-port clinical development programs.

KCAS provides a full range of high-quality bioanalytical services including method

development, validation and high-throughput sample analy-sis for small and large molecule compounds on biologicalsamples from preclinical and clinical studies. As a partnerin “next IND”, KCAS conducts bioanalysis of TK, PK, andBiomarker/PD samples. With a large database of fully-val-idated bioanalytical assays, KCAS has the ability to directly

assist with your drug development programs.Cedarburg Hauser provides a full range of drug substance process development and

manufacturing capabilities covering synthetic, semi-synthetic and natural compounds in-cluding an assurance of purity and stability. As a partner in “next IND,” Cedarburg Hauserfacilitates cost effective optimization of the routes of synthesis and unit operations relatedto the production of drug substance under cGMP at scales ranging from Phase I-Phase IIIand commercialization.

Formurex is a pharmaceutical CRO that aims to provide the best services in prefor-mulation, formulation development, analytical, stability and GMP manufacturing. As apartner in “next IND”, Formurex assists clients with physicochemical characterizationand dosage form development optimization to improve bioavailability and PK/PD of thedrug product.

Vince & Associates Clinical Research has been providing clinical research servicesto the global biopharmaceutical industry for over a decade. An experienced team ofclinical research professionals focusing on quality research data has become a premierUS clinical research site by utilizing The Physician Research Model. As a partner in“next IND”, Vince & Associates assists clients with the design and execution of effi-cient and optimal clinical protocols to achieve the desired clinical endpoints for a va-riety of therapeutic areas.

For more information, visit www.mynextind.com or stop by Booth #1441.

next IND Helps to Revolutionize the Drug Development Process